Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01950390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

NIH

Sponsor class

Conditions

Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Unresectable Melanoma

Interventions

BIOLOGICAL: Bevacizumab
BIOLOGICAL: Ipilimumab

Sponsor

National Cancer Institute (NCI)